Topic

Insurance Approval

A collection of 952 issues

How to Get Tepezza (teprotumumab) Covered by Humana in Pennsylvania: Prior Authorization Guide and Appeals Process

Answer Box: Getting Tepezza Covered by Humana in Pennsylvania Tepezza (teprotumumab) requires prior authorization from Humana for thyroid eye disease (TED) treatment. To get approved: (1) Your ophthalmologist or endocrinologist must document active, moderate-to-severe TED with Clinical Activity Score ≥3 and proptosis measurements, (2) Submit prior authorization through Humana'
6 min read

How to Get Signifor LAR (Pasireotide) Covered by Cigna in Pennsylvania: Prior Authorization Requirements and Appeals Process

Quick Answer: Getting Cigna Coverage for Signifor LAR in Pennsylvania Cigna requires prior authorization for Signifor/Signifor LAR (pasireotide) with strict medical necessity criteria. Your endocrinologist must document: confirmed acromegaly or Cushing's disease diagnosis, elevated IGF-1/UFC levels, failed surgery or ineligibility, and trial/failure of first-generation somatostatin
6 min read

How to Get Breyanzi (lisocabtagene maraleucel) Covered by Cigna in Illinois: Complete Guide to Prior Authorization, Appeals, and State Resources

Answer Box: Getting Breyanzi Covered by Cigna in Illinois Fastest path to approval: Submit your prior authorization through CoverMyMeds or ExpressPAth with complete medical documentation showing refractory large B-cell lymphoma or CLL/SLL with transformation. First step today: Verify your plan covers specialty drugs through Express Scripts/Accredo, then gather
5 min read

How to Get Rystiggo (Rozanolixizumab-noli) Covered by Blue Cross Blue Shield in Georgia: Forms, Appeals, and Success Strategies

Quick Answer: Getting Rystiggo Covered in Georgia Yes, Blue Cross Blue Shield Georgia covers Rystiggo (rozanolixizumab-noli) for generalized myasthenia gravis, but prior authorization is required. Your fastest path to approval: 1) Confirm your antibody status (AChR+ or MuSK+) with your neurologist, 2) Document failed standard therapies, and 3) Submit the
6 min read